Janvier Labs completed the acquisition of a majority stake in Firalis Molecular Precision for €27m.

Synopsis

Janvier Labs, a biomedical research company, completed the acquisition of a majority stake in Firalis Molecular Precision, a provider of advanced BioAnalytical Testing services, for €27m.

Principals

target

Firalis Molecular Precision

bidder

Janvier Labs

Show Details & Financials

Did you work on this deal?

Claim Deal

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Claim Deal

Market Context

Sort

Seller Team (3)

hüseyin firat

CEO at FIRALIS MOLECULAR PRECISION

Manager

target

Deal

£ 24 M

Total Value

arik alter

M&A Director at Rothschild & Co

Financial Advisor

target

Deals

£ 765 M

Total Value

elena coluccelli guerin

Partner and Co-Head of Healthcare France at Rothschild & Co

Financial Advisor

target

Deals

£ 24 M

Total Value

Bidder Team (1)

thomas janvier

CEO at JANVIER LABS

Manager

bidder

Deals

£ 24 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy